The Peptide Reset

If you’re a high-functioning woman in your 40s who has been told her labs are “normal” but knows something has shifted — the energy, the recovery, the mirror, the gut, the hair — this is the episode that explains what’s actually happening. Dr. Tracy Page walks through the seven systems that decline in midlife, the peptide class quietly transforming functional medicine, and the FDA decision in April 2026 that just changed the regulatory landscape. Featuring the case of “Melissa,” a 48-year-old patient with a 10-year history of escalating symptoms hidden inside a high-functioning life. 
 
In this episode, you will learn: why the standard reference range is failing midlife women; the actual statistics on muscle, bone, hormone, immune, and gut decline after 40; what peptides are and how they differ from hormones and pharmaceuticals; the FDA Category 2 reclassification of April 23, 2026, and what the July PCAC meeting will and will not decide; the seven peptide frontiers — from CJC-1295 and ipamorelin to BPC-157, thymosin alpha-1, larazotide, and tesamorelin; and the order-of-operations protocol used in clinical practice to sequence them safely.

If you’ve been told your symptoms are “just menopause,” this episode offers a powerful new perspective. Listen to discover why your gut may hold the key to feeling like yourself again.